Life Science Partner has recruited Tom Afzal to become Chief Executive Officer and Board Member of Novum Medical.

Novum Medical is a private, medical device and orthopedics company developing advanced orthobiomaterials that are structurally sound and compatible to the body. Having shown success with their current applications in extremities, the company is entering the spine industry with their first cervical implant device (currently in FDA IDE clinical trials). The technology has already shown promising and superior results when compared to other implants such as titanium or PEEK plastic.

Afzal is a leader in the spine, orthopedic and cardiovascular industries. He will lead Novum in transforming the spine surgery and orthopedic markets, while continuing the growth of the company. As a co-Founder and former Chief Executive Officer of Spinal Kinetics, Afzal brought his company to profitability and led the commercial strategy for their artificial discs. He also gained extensive experience building international businesses across Europe, raising sales to over 60,000 implants in over 20 countries.

Prior to Spinal Kinetics, Afzal was the Chief Executive Officer of Cardiovention. He raised $45 M from venture capital firms, established U.S., German, and Swiss sales organizations, filed his own patents, and helped create a team to develop minimally invasive products for cardiovascular surgery.

Afzal spent the early 90s working overseas in Germany for Life System Medizintechnik and Krauth Medical, achieving annual revenue growth and leading Life System through its acquisition by Krauth Medical. He graduated from San Diego State University majoring in Business Administration and minoring in Finance.

Afzal will play a critical role in raising funds for Novum Medical with his financing background and connections in the spine, cardiovascular and sports medicine industries. As the company completes its FDA IDE clinical trials for their Vitrium cervical interbody spinal fusion device, Afzal will leverage his strengths in commercial and operational leadership to advance the company to its next level of growth.

Novum Medical is a private, medical device and orthopedics company developing advanced orthobiomaterials that are structurally sound and compatible to the body. Having shown success with their current applications in extremities, the company is entering the spine industry with their first cervical implant device (currently in FDA IDE clinical trials). The technology has already shown promising and superior results when compared to other implants such as titanium or PEEK plastic.

Afzal is a leader in the spine, orthopedic and cardiovascular industries. He will lead Novum in transforming the spine surgery and orthopedic markets, while continuing the growth of the company. As a co-Founder and former Chief Executive Officer of Spinal Kinetics, Afzal brought his company to profitability and led the commercial strategy for their artificial discs. He also gained extensive experience building international businesses across Europe, raising sales to over 60,000 implants in over 20 countries.

Prior to Spinal Kinetics, Afzal was the Chief Executive Officer of Cardiovention. He raised $45 M from venture capital firms, established U.S., German, and Swiss sales organizations, filed his own patents, and helped create a team to develop minimally invasive products for cardiovascular surgery.

Afzal spent the early 90s working overseas in Germany for Life System Medizintechnik and Krauth Medical, achieving annual revenue growth and leading Life System through its acquisition by Krauth Medical. He graduated from San Diego State University majoring in Business Administration and minoring in Finance.

Afzal will play a critical role in raising funds for Novum Medical with his financing background and connections in the spine, cardiovascular and sports medicine industries. As the company completes its FDA IDE clinical trials for their Vitrium cervical interbody spinal fusion device, Afzal will leverage his strengths in commercial and operational leadership to advance the company to its next level of growth.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds in medicine, science, and industry enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of David Ramsingh as Vice President, Clinical & Medical Affairs – Critical Care at Edwards Lifesciences.

Edwards is a global leader in patient-focused medical innovations. Recently, their Critical Care division has expanded its role in AI-supported predictive software solutions that allow ICU physicians to make better patient care decisions. In doing so, the team sought an integrative leader to oversee clinical research activities, including clinical trials, data management, and systems development to help with future product approval. An anesthesiologist and researcher in hemodynamic monitoring and echocardiology, Ramsingh has a combination of skills which positioned him for this opportunity.

Ramsingh will direct multiple functions within clinical and medical affairs, oversee research activities around clinical trials, data management, and system development for future product approvals. In addition, he will oversee Edwards’ high standard of professional education through its Global Professional Development program.

Ramsingh possess valuable skills and experience, having come from Loma Linda University and University of California at Irvine, where he developed an innovative teaching program for anesthesiologists to apply whole-body, point-of-care ultrasound exams. At Loma Linda, his research focused on the use of ultrasound technology to improve perioperative care.

As the Director of Clinical Research and Perioperative Ultrasound at Loma Linda University Medical Center, Ramsingh spent most of his time leading a research team that he developed to focus on hemodynamic monitoring devices, partnering with corporate sponsors such as Edwards, Masimo, and General Electric. Ramsingh earned his medical degree from the Medical College of Georgia. He completed his residency in anesthesiology at Loma Linda University, and he was a cardiothoracic fellow at the University of California in Los Angeles.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

­­Life Science Partner is pleased to announce the successful placements of Canary Medical’s Senior Research & Development team.

Canary Medical is an innovative MedTech company modernizing smart implants in the orthopedic, cardiovascular, and aesthetic markets. The company integrates a sensor and microprocessor system into FDA-cleared implantable medical devices to remotely gather biometric data and transmit it back to physicians via the cloud to give real-time insights about the performance and safety of these products.

Partnering with Canary at its very inception, Life Science Partner recruited Chief Technology Officer Jeff Gross, VP of Technology Development Mark Phelps, VP of Research and Development Peter Schiller, VP of Operations Balakrishnan Shankar, and Senior Director of Regulatory Affairs & Quality Assurance Nora York. In turn, we worked with these leaders to recruit their technical teams who have been superstars in the fields of electronics, medical devices, and cloud software. These 7 talented, senior R&D engineers will help propel the company’s platform in telemedicine and medical devices.

The recruitment of Lan Herrington as Senior Quality Manager, Luis Dogue as Manager of Data Software, Kevin Gemmell as Senior Biomedical Engineer, David Mejia as Senior Manufacturing Engineer, Matthew Sturtevant as Senior Electromechanical Engineer, Ryan Peck as Senior Quality Engineer, and Reghu Rajan, MBA as Senior Systems Engineer will drive Canary Medical toward commercialization while pursuing their technology’s vast array of potential applications beyond the orthopedic space. They each bring to the company a track record of success and a combined expertise in the orthopedic and cardiovascular space with a broad range of experience from the medical device, healthcare, and information technology industries.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Chad Kolean as Vivex Biologics’ Chief Financial Officer.

Vivex Biologics is a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies. They have a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedics, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sport medicine, and wound care. Vivex is preparing for its next stage of growth with the launch of its new product, VIA Disc. This product will be used for the treatment of Degenerative Disc Disease (DDD). As the company continues to grow in the spine and biologics industry, it sought a seasoned Chief Financial Officer who understood the landscape of this field.

Kolean previously served as the Chief Financial Officer of Titan Spine, a medical device surface technology company. One of his major milestones in preparing Titan for success was controlling and managing inventory and manufacturing challenges. His attitude helped put the company’s financial house in order.

He was also Chief Financial Officer of Cellectar Biosciences, a clinical stage biopharmaceutical company, where he restructured management and raised funds, which led to an uplisting on the NASDAQ Capital Market. Before that, Kolean served for Pioneer Surgical Technologies as their Chief Financial Officer. He was responsible for the financial aspects of leadership restructuring, development and execution, treasury, board support, investor relations, and operations.

Kolean’s arrival will provide tremendous guidance and leadership to Vivex Biologics as it prepares itself for the next stage of growth and development and the launch of a new product in the biologics space. By leveraging Kolean’s experience as a financial leader in the spine and orthopaedic industry, the company hopes for continued growth and preparation for a future financing event.  

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Life Science Partner is pleased to announce the recruitment of Ron Hebert as Vivex Biologics’ Vice President of Marketing.

Vivex Biologics, a leading regenerative medicine company that markets tissue technology products and cellular therapies focused on orthopaedic applications with an emphasis on spine related therapies, has developed a diverse portfolio of current products including cellular bone matrices, amniotic tissue, general orthopaedic treatments, and sports medicine products to meet the therapeutic demand in the areas of spine, dental, sports medicine, and wound care. The next stage of the company’s growth is the launch of its new product, VIA Disc. This viable allograft is delivered by a minimally invasive procedure and will be used for the treatment of Degenerative Disc Disease (DDD). As the company continues to grow in the spine and biologics space, it sought a talented Vice President, Marketing who could lead the branding campaigns and support the efforts of the geographic and product-focused sales forces.

Hebert was the Vice President, Marketing, Communications, and Growth Initiatives at MEDNAX, a physician-led healthcare organization that partners with hospitals and health systems to provide a wide range of clinical services. Coming into one of the largest physician-owned/operated national staffing companies, Hebert refocused the company strategy to the hospital-customer and provided them with proof of value. He also created programs that productized services such as women/children, anesthesia, and ENT/plastics specialists.

He also spent a majority of his marketing career at Beckman Coulter serving as Director of Global Strategic Marketing and Global Product Management and Strategy. Hebert’s notable accomplishment during his time here was being able to provide innovation within the traditional product portfolio of the hematology unit.

With the arrival of Hebert, Vivex will gain a marketing leader, an integrative thinker that focuses on the customer needs, a person with a demonstrated track record of successful product launches, and a strong communicator. By utilizing Hebert’s expertise in hospital-based marketing, Vivex Biologics hopes for continued growth of its new products and a skilled manager of its existing lines.

About Life Science Partner

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.